Trade Report: The Joel Ackerman Acquires 7,300 Shares of Champions Oncology Inc (CSBR) Stock

The Joel Ackerman Acquires 7,300 Shares of Champions Oncology Inc (CSBR) Stock

Champions Oncology Inc (OTCMKTS:CSBR) CEO Joel Ackerman acquired 7,300 shares of the firm’s stock in a transaction on Friday, October 14th. The stock was purchased at an average price of $1.67 per share, with a total value of $12,191.00. Following the acquisition, the chief executive officer now owns 1,035,466 shares of the company’s stock, valued at approximately $1,729,228.22. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Joel Ackerman also recently made the following trade(s): On Friday, October 7th, Joel Ackerman acquired 8,202 shares of Champions Oncology stock. The stock was purchased at an average price of $1.63 per share, with a total value of $13,369.26. On Friday, September 23rd, Joel Ackerman acquired 33 shares of Champions Oncology stock. The stock was purchased at an average price of $1.65 per share, with a total value of $54.45. On Wednesday, September 21st, Joel Ackerman acquired 5,000 shares of Champions Oncology stock. The stock was purchased at an average price of $1.66 per share, with a total value of $8,300.00.

Champions Oncology Inc (OTCMKTS:CSBR) opened at 1.68 on Tuesday. The firm has a 50-day moving average price of $1.66 and a 200-day moving average price of $2.52. Champions Oncology Inc has a 12-month low of $1.11 and a 12-month high of $5.46. The company’s market cap is $18.42 million.

Champions Oncology (OTCMKTS:CSBR) last released its quarterly earnings data on Friday, September 9th. The company reported ($0.15) earnings per share (EPS) for the quarter. The business earned $3.70 million during the quarter.

Related posts

Leave a Comment